Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

ClinicalTrials.gov ID: NCT07210515

Public ClinicalTrials.gov record NCT07210515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 8, 2026, 11:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Triple-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous AMBTX-01 (Neridronate) for Treatment of Complex Regional Pain Syndrome Type 1 (CRPS-RISE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1

Study identification

NCT ID
NCT07210515
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ambros Therapeutics, Inc.
Industry
Enrollment
270 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 13, 2026
Primary completion
Nov 30, 2027
Completion
Dec 31, 2027
Last update posted
Aug 31, 2026

2026 – 2028

United States locations

U.S. sites
26
U.S. states
14
U.S. cities
26
Facility City State ZIP Site status
Ambros Clinical Trial Site Phoenix Arizona 85032 Recruiting
Ambros Clinical Trial Site Tucson Arizona 85710 Recruiting
Ambros Clinical Trial Site Little Rock Arkansas 72205 Recruiting
Ambros Clinical Trial Site La Jolla California 92093 Recruiting
Ambros Clinical Trial Site Napa California 94558 Recruiting
Ambros Clinical Trial Site Pasadena California 91105 Recruiting
Ambros Clinical Trial Site Tustin California 92780 Recruiting
Ambros Clinical Trial Site Washington D.C. District of Columbia 20006 Recruiting
Ambros Clinical Trial Site Brandon Florida 33511 Recruiting
Ambros Clinical Trial Site Daytona Beach Florida 32117 Recruiting
Ambros Clinical Trial Site Pembroke Pines Florida 33025 Recruiting
Ambros Clinical Trial Site Lawrenceville Georgia 30046 Recruiting
Ambros Clinical Trial Site Newnan Georgia 30265 Recruiting
Ambros Clinical Trial Site Orland Park Illinois 60462 Recruiting
Ambros Clinical Trial Site Overland Park Kansas 66210 Recruiting
Ambros Clinical Trial Site Reno Nevada 89511 Recruiting
Ambros Clinical Trial Site Shrewsbury New Jersey 07702 Recruiting
Ambros Clinical Trial Site Charlotte North Carolina 28211 Recruiting
Ambros Clinical Trial Site Wilmington North Carolina 28412 Recruiting
Ambros Clinical Trial Site Winston-Salem North Carolina 27103 Recruiting
Ambros Clinical Trial Site Dayton Ohio 45432 Recruiting
Ambros Clinical Trial Site Fort Worth Texas 76244 Recruiting
Ambros Clinical Trial Site Houston Texas 77079 Recruiting
Ambros Clinical Trial Site Lubbock Texas 79410 Recruiting
Ambros Clinical Trial Site Mesquite Texas 75150 Recruiting
Ambros Clinical Trial Site Charlottesville Virginia 22903 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07210515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 31, 2026 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07210515 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →